Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine in New York City
24. Mai 2022 19:23 ET
|
Rensselaer Polytechnic Institute
NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai recently announced the creation of the Center for Engineering and...
LymeMIND, a division of the Icahn School of Medicine at Mount Sinai, to Host LymeMIND 2020 Virtual Conference on October 10
09. September 2020 09:00 ET
|
LymeMIND
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- LymeMIND, the data coordination center of the Cohen Lyme & Tickborne Disease Initiative, housed at the Icahn School of Medicine at Mount Sinai, today...
Mount Sinai Icahn School of Medicine’s Dr. Robert S. Rosenson Receives Foundation of the National Lipid Association 2019 Clinician/Educator Award
18. Mai 2019 17:45 ET
|
National Lipid Association
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- Robert S. Rosenson, MD, FACC, FACP, FAHA, FESC, FNLA, FACCP, Professor of Medicine and Director of Cardiometabolic Disorders at the Icahn School of Medicine...
Cognition Therapeutics Expands Clinical Expertise on Medical Advisory Board with Addition of Drs. Mary Sano and Philip Scheltens
05. April 2019 08:02 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, April 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative...
American Health Council Names Matilde Inglese, MD, Ph.D. to Education Board
24. April 2017 10:42 ET
|
American Health Council
NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- Dr. Matilde Inglese, Associate Professor of Neurology, Radiology and Neuroscience at the Icahn School of Medicine at Mount Sinai has been selected to...
Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support
18. November 2013 18:14 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...